Absence of Pathognomonic or Inflammatory Patterns in Cardiac Biopsies From Patients With Brugada Syndrome

Background—Brugada syndrome (BrS) is characterized by the presence of coved ST-segment elevations in the right precordial leads (so-called type I ECG) and additional clinical features. Caused by cardiac ion channel gene mutations, BrS may be associated with ventricular and atrial conduction disturbances as well as ventricular fibrillation. Recent studies have discussed whether BrS is merely a primary electric disorder or whether inflammatory or other histopathologic abnormalities in the right ventricle (RV) underlie the ECG phenotype. Methods and Results—We retrospectively analyzed BrS biopsy samples from 21 unrelated patients for histopathologic abnormalities (hypertrophy, fibrosis, inflammation, fatty tissue) together with the patients’ clinical, genetic, and imaging data. Eleven patients (52%) had normal RV imaging (by angiography, echocardiography, or cardiac MRI). Results of myocardial biopsies were normal in 3 patients (14%) and revealed mostly moderate abnormalities in the others. Four patients (19%) had predominant fatty tissue in the RV myocardium. Using immunohistochemistry and conventional tissue staining, we could not detect inflammatory tissue changes, an observation compatible with the clinical absence of signs for myocarditis. Conclusions—Imaging and histopathologic evaluation may detect moderate but uncharacteristic cardiac abnormalities in patients with BrS. None of the patients had arrhythmogenic RV cardiomyopathy or overt myocarditis. Only in a small subset did predominant histopathologic abnormalities in the biopsy samples of the RV outflow tract occur that could provide a link to the ECG phenotype. A variety of mechanisms, including genetic and structural RV alterations, may underlie the Brugada ECG phenotype.

[1]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2009, The Lancet.

[2]  E. Behr,et al.  The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. , 2008, The Journal of clinical investigation.

[3]  Sean Connors,et al.  Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.

[4]  P. C. Viswanathan,et al.  Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias , 2007, Circulation.

[5]  Michel Haïssaguerre,et al.  Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death , 2007, Circulation.

[6]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[7]  Arthur A M Wilde,et al.  Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome. , 2005, Cardiovascular research.

[8]  S. Priori,et al.  Cardiac Histological Substrate in Patients With Clinical Phenotype of Brugada Syndrome , 2005, Circulation.

[9]  J. D. de Bakker,et al.  Impaired Impulse Propagation in Scn5a-Knockout Mice: Combined Contribution of Excitability, Connexin Expression, and Tissue Architecture in Relation to Aging , 2005, Circulation.

[10]  D. Gros,et al.  Mouse Model of SCN5A-Linked Hereditary Lenègre’s Disease: Age-Related Conduction Slowing and Myocardial Fibrosis , 2005, Circulation.

[11]  Wataru Shimizu,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[12]  Jeffrey L. Anderson,et al.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.

[13]  R. Razmi.  Magnetic Resonance Imaging Findings in Patients with Brugada Syndrome , 2004, Journal of cardiovascular electrophysiology.

[14]  A. Wilde,et al.  Delay in Right Ventricular Activation Contributes to Brugada Syndrome , 2004, Circulation.

[15]  C. Antzelevitch.  Cellular basis and mechanism underlying normal and abnormal myocardial repolarization and arrhythmogenesis , 2004, Annals of medicine.

[16]  Bortolo Martini,et al.  More evidence-based data are required for a consensus on the aetiology of the so-called Brugada Syndrome. , 2003, European heart journal.

[17]  G. Breithardt,et al.  Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: Different incidences in familial and sporadic disease , 2003, Human mutation.

[18]  Lucas J Herfst,et al.  Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System , 2003, Circulation research.

[19]  T. Kurita,et al.  Abnormal response to sodium channel blockers in patients with Brugada syndrome: augmented localised wall motion abnormalities in the right ventricular outflow tract region detected by electron beam computed tomography , 2003, Heart.

[20]  R. Hauer,et al.  Proposed diagnostic criteria for the Brugada syndrome: consensus report. , 2002, Circulation.

[21]  G. Breithardt,et al.  Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats. , 2002, European heart journal.

[22]  Jamie I Vandenberg,et al.  Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Barmada,et al.  Clinical and Molecular Heterogeneity in the Brugada Syndrome: A Novel Gene Locus on Chromosome 3 , 2002, Circulation.

[24]  G Thiene,et al.  Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings , 2001, Cardiovascular research.

[25]  D. Corrado,et al.  Sudden cardiac death in young people with apparently normal heart. , 2001, Cardiovascular research.

[26]  M. Gardner,et al.  Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. , 1998, Circulation.

[27]  R. Virmani,et al.  Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? , 1998, Circulation.

[28]  G. Breithardt,et al.  Genetic basis and molecular mechanism for idiopathic ventricular fibrillation , 1998, Nature.

[29]  S. Hamada,et al.  Arrhythmogenic right ventricular cardiomyopathy underlies syndrome of right bundle branch block, ST-segment elevation, and sudden death. , 1998, The American journal of cardiology.

[30]  J. Brugada,et al.  Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. , 1998, Circulation.

[31]  A. Angelini,et al.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.

[32]  A. Angelini,et al.  Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy. , 1996, American heart journal.

[33]  D. Corrado,et al.  Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. , 1996, Journal of the American College of Cardiology.

[34]  G. Thiene,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[35]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[36]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[37]  H. Osher,et al.  ELECTROCARDIOGRAPHIC PATTERN SIMULATING ACUTE MYOCARDIAL INJURY , 1953, The American journal of the medical sciences.

[38]  Simona Casini,et al.  Sodium channel dysfunction in inherited and acquired cardiac diseases , 2008 .

[39]  G. Thiene,et al.  Autopsy and Endomyocardial Biopsy Findings , 2007 .

[40]  G. Thiene,et al.  Arrhythmogenic RV Cardiomyopathy/Dysplasia , 2007 .

[41]  Sue Eckstein.  Ethical principles for medical research involving human subjects , 2003 .

[42]  J. Towbin,et al.  The Brugada syndrome: clinical, electrophysiologic and genetic aspects. , 1999, Journal of the American College of Cardiology.